NF PROTOCOL 108: A Phase II Study of Binimetinib in Children and Adults with NF1 associated Plexiform Neurofibromas (PNOC010)
Brief description of study
If you have been diagnosed with NF1 associated Plexiform Neurofibromas, you or your child may qualify for this Phase II study. The main goal of this study is to see if the drug binimetinib is safe and effective in treating patients who have NF1 associated Plexiform Neurofibromas.
Clinical Study Identifier: s18-00194
ClinicalTrials.gov Identifier: NCT03231306
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
